1 / 2

EPSA - PowerPoint PPT Presentation

  • Uploaded on

#13 #14 #15 #16 #17. EPSA. Information Letter. Dear reader,.

I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
Download Presentation

PowerPoint Slideshow about ' EPSA' - tierra

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript


#14 #15




Information Letter

Dear reader,

  • This has been a very important year for EPSA, launching new projects and developing new strategic co-operations. The Information Letter is a project that wishes to be a platform of information, gathering updated information about general pharmaceutical concerns.

  • Your opinion and feedback is for us extremely important. We would like to know how enthusiastic you are about this publication and how can we help you in you academic and professional development.

  • By this we re-enforce that any proposal for the next

  • EPSA Information Letter is more than welcome.

  • Happy New 2007!

Ana Cristina Franco Spínola

EPSA Information Officer 06/07

e-mail: [email protected]

mobile: 00351918293540

News & Articles

European Association of Hospital Pharmacists

Quality of care, quality of life

Results of the ESMO Medical Oncology Status in Europe Survey will help to identify the improvements necessary to reduce the disparities in the quality of cancer care across Europe and show the need to recognise medical oncology as a specialty within the multidisciplinary team of cancer care.Access full article.

HIV/AIDS Surveillance in Europe

Surveillance report

There are an estimated 740 000 people living with HIV or AIDS in western and central Europe today, and 1.7 million in the neighbouring countries of eastern Europe and Central Asia [1]. The proportion of undiagnosed HIV infections is estimated to be as high as 30% in the European Union (EU), and likely to be higher in neighbouring countries. People who have not yet been diagnosed are unaware that they are infected, and therefore cannot benefit from treatment and care, and may unknowingly transmit HIV to others.Access full article.


Why drugs fall short in large -stage trials

The third and last stage of clinical testing is meant to confirm that medications under development are safe and effective. However, McKinsey research finds that 42 percent of drug candidates do not surmount this hurdle. Worse, fully half of the failures were caused by a lack of efficacy.Download article.

News & Articles


A European strategy for global health?

The European Foundation Centre (EFC) recently launched a publication entitled European Perspectives on Global Health: A Policy Glossary, which urges the development of a European strategy for global health.Access webpage.Download glossary.


EAHP: European Association of Hospital Pharmacists

EJHP Practice and EJHP Science

You can find here the complete articles in the EJHP Practice (European Journal of Hospital Pharmacy Practice). Check also the EJHP Science.

European Federation of Pharmaceutical Sciences

EUFEPS Newsletter

The EUFEPS Newsletter, published quarterly since 1992, is an important vehicle for communication within EUFEPS. The ambition has been – and it still is – that the EUFEPS Newsletter communicate clear and concise information, primarily for the EUFEPS membership. Access newsletter

For further information please contact

European Pharmaceutical Students’ Association

19-21 Rue du Luxembourg

1000 Brussels – Belgium

e-mail: [email protected]

web: www.epsa-online.org

“Bringing Pharmacy, Knowledge

and Students Together”


EPSA is supported by the grant of the European Community

INGO with participatory status in the Council of Europe